Literature DB >> 12086857

Molecular mechanisms of lymphangiogenesis in health and disease.

Kari Alitalo1, Peter Carmeliet.   

Abstract

Studies of the last decades have revealed the importance of angiogenesis for normal growth and for the pathogenesis of numerous diseases. Much less studied is lymphangiogenesis, the growth of lymphatic vessels, which drain extravasated fluid, proteins, and cells and transport them back to the venous circulation. Nonetheless, insufficient lymphangiogenesis causes incapacitating lymphedema, while lymphatic growth around tumors may facilitate metastatic spread of malignant cells that ultimately kill the patient. The recent discovery of the key lymphangiogenic factors VEGF-C and VEGF-D and their receptor VEGFR-3 has allowed novel insights into how the lymphatic vessels and blood vessels coordinately grow and affect human disease. In addition, these studies have opened novel diagnostic and therapeutic avenues for the treatment of lymphedema and metastasis. This overview highlights the recent insights and developments in the field of lymphatic vascular research.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12086857     DOI: 10.1016/s1535-6108(02)00051-x

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  175 in total

1.  Endothelial cell Bcl-2 and lymph node metastasis in patients with oral squamous cell carcinoma.

Authors:  Sandra B C Tarquinio; Zhaocheng Zhang; Kathleen G Neiva; Peter J Polverini; Jacques E Nör
Journal:  J Oral Pathol Med       Date:  2011-09-21       Impact factor: 4.253

2.  Double target for tumor mass destruction.

Authors:  Pipsa Saharinen; Kari Alitalo
Journal:  J Clin Invest       Date:  2003-05       Impact factor: 14.808

3.  B lymphocyte-specific c-Myc expression stimulates early and functional expansion of the vasculature and lymphatics during lymphomagenesis.

Authors:  Alanna Ruddell; Pau Mezquita; Kimberly A Brandvold; Andrew Farr; Brian M Iritani
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

Review 4.  The new era of the lymphatic system: no longer secondary to the blood vascular system.

Authors:  Inho Choi; Sunju Lee; Young-Kwon Hong
Journal:  Cold Spring Harb Perspect Med       Date:  2012-04       Impact factor: 6.915

5.  Cellular fibronectin 1 promotes VEGF-C expression, lymphangiogenesis and lymph node metastasis associated with human oral squamous cell carcinoma.

Authors:  Yoshihiro Morita; Kenji Hata; Masako Nakanishi; Tetsuji Omata; Nobuo Morita; Yoshiaki Yura; Riko Nishimura; Toshiyuki Yoneda
Journal:  Clin Exp Metastasis       Date:  2015-08-29       Impact factor: 5.150

6.  Vascular endothelial growth factor-C induces lymphangitic carcinomatosis, an extremely aggressive form of lung metastases.

Authors:  Suvendu Das; Daniel S Ladell; Simona Podgrabinska; Vladimir Ponomarev; Chandandeep Nagi; John T Fallon; Mihaela Skobe
Journal:  Cancer Res       Date:  2010-02-23       Impact factor: 12.701

7.  Expression of VEGFR3 in glioma endothelium correlates with tumor grade.

Authors:  S J Grau; F Trillsch; J Herms; N Thon; P J Nelson; J-C Tonn; R Goldbrunner
Journal:  J Neurooncol       Date:  2006-11-17       Impact factor: 4.130

8.  Lymphatic vessel density and VEGF-C expression are significantly different among benign and malignant thyroid lesions.

Authors:  Eduardo Anselmo Garcia; Kleber Simões; Alda Wakamatsu; Rodrigo Albergaria Ressio; Venâncio Avancini Ferreira Alves; Adhemar Longatto-Filho; Roberto Souza Camargo
Journal:  Endocr Pathol       Date:  2010-06       Impact factor: 3.943

9.  Lack of lymphatic vessel phenotype in LYVE-1/CD44 double knockout mice.

Authors:  Mai X Luong; Joshua Tam; Qingcong Lin; Jeroen Hagendoorn; Kathryn J Moore; Timothy P Padera; Brian Seed; Dai Fukumura; Raju Kucherlapati; Rakesh K Jain
Journal:  J Cell Physiol       Date:  2009-05       Impact factor: 6.384

10.  A FAK scaffold inhibitor disrupts FAK and VEGFR-3 signaling and blocks melanoma growth by targeting both tumor and endothelial cells.

Authors:  Elena Kurenova; Deniz Ucar; Jianqun Liao; Michael Yemma; Priyanka Gogate; Wiam Bshara; Ulas Sunar; Mukund Seshadri; Steven N Hochwald; William G Cance
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.